Stocktoria

AtaiBeckley Inc. ATAI

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-18
Chart by TradingView
4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024
Financials
Revenue$4.1M$308,000
Operating income-$644.1M-$102.7M
Net income-$660.0M-$149.3M
Operating cash flow-$102.7M-$82.4M
Free cash flow-$103.6M-$82.4M
Total assets$292.7M$159.4M
Total liabilities$70.7M$42.8M
Shareholders' equity$221.9M$116.6M
Ratios
Operating margin-15751.1%-33341.2%
Net margin-16142.0%-48464.0%
FCF margin-2533.0%-26767.2%
Return on assets-225.5%-93.7%
Return on equity-297.5%-128.1%
Debt / equity0.00×0.12×
Current ratio11.743.21
Revenue growth1227.6%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.685,424$2.4M

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0002081043 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.